JBS NV is a protein food company, selling protein products, which include fresh and frozen cuts of beef, pork, lamb, fish, whole chickens, and chicken parts, to retailers, and foodservice companies... Show more
JBS S.A. is the world's largest meat processing company by sales, with operations spanning beef, pork, poultry, lamb, and prepared foods across more than 180 countries. Headquartered in São Paulo, Brazil, and listed on the New York Stock Exchange under ticker JBS, the company operates over 250 production facilities and employs approximately 280,000 people globally. Its portfolio includes major brands such as Swift, Seara, Pilgrim's Pride, Friboi, and Moy Park, with significant market leadership positions in the United States, Brazil, Australia, and Europe. JBS benefits from geographic and protein diversification — a structural advantage that helps buffer earnings when individual segments, such as U.S. beef, face cyclical headwinds. The company also operates adjacent businesses in leather, biodiesel, collagen, and metal packaging, leveraging vertical integration to optimize supply chain economics. Investors track JBS closely as a bellwether for global protein demand trends, commodity price cycles, and agricultural trade policy.
Over the last 30 days, JBS stock climbed from approximately $11.91 on July 10 to $14.23 by the August 7 close — a gain of roughly 19.5%. The recovery was sharp and concentrated in the final week of July, when the stock jumped over 8% in a single session on July 27 following the USDA's Mexican cattle import announcement, and continued climbing in subsequent sessions as analyst upgrades reinforced positive sentiment. The stock touched a 52-week low of $11.49 during this period before reversing course.
Looking at the broader quarter, the picture is more mixed. From mid-May through mid-July, JBS trended steadily lower, weighed down by weak U.S. beef margins, a Q1 earnings miss, and broader protein sector oversupply concerns. The stock declined roughly 5% over the trailing three-month period through early August, meaning the 30-day rally has largely offset — but not fully erased — the prior quarter's weakness. The recovery has brought JBS back toward its 50-day moving average of approximately $12.26, though it remains well below its 200-day moving average near $14.69.
The most powerful catalyst behind JBS's 19% rally was the U.S. Department of Agriculture's July 27 announcement that it plans to lift a more than year-long ban on Mexican cattle imports. The ban, imposed to contain the New World screwworm, had severely constrained the supply of feeder cattle flowing into U.S. feedlots. Mexico typically sends roughly one million calves across the border annually. The resumption is expected to ease cattle shortages, lower input costs for meatpackers, and improve margins at JBS's U.S. beef operations — the company's largest segment, representing roughly one-third of net sales. Live cattle futures dipped approximately 1.5% on the news, while JBS shares surged 10% in the same session.
The following day, JPMorgan analyst Lucas Ferreira upgraded JBS from Neutral to Overweight with an $18 price target, citing attractive valuation and the improving supply outlook. This marked a turning point in analyst sentiment after several months of cautious positioning. Barclays, which maintained its Overweight rating, trimmed its target from $21 to $20 in mid-July ahead of Q2 results, citing near-term beef headwinds and tough year-over-year comparisons in chicken. Overall, the consensus among seven analysts remains a Buy rating with an average price target of approximately $18.75, implying additional upside from current levels.
On the fundamental side, JBS's last reported quarter (Q1 2026) showed record net revenue of $21.61 billion, up 10.7% year-over-year, but EPS of $0.20 missed the $0.28 consensus. The U.S. beef division posted a significant negative EBITDA of approximately $230 million. Still, strength in Brazilian beef, Australian operations, and the Seara processed foods segment provided partial offsets, demonstrating the resilience of JBS's global diversification model.
JBS's quarterly performance was shaped by a tug-of-war between resilient global demand and severe margin compression in North American protein markets. The U.S. beef segment has been mired in a challenging cattle cycle, with tight domestic supply pushing up livestock costs even as consumer demand remained relatively stable. This dynamic has persisted for several quarters and has been the primary drag on consolidated earnings. Meanwhile, Pilgrim's Pride, the U.S. chicken giant majority-owned by JBS, reported a 48% drop in adjusted EBITDA in its Q2 results released July 30, as an industry-wide oversupply of chicken pressured prices and margins.
Geopolitical and trade factors also played a role. A 50% U.S. tariff on Brazilian beef exports — including products from JBS's Brazilian facilities — created additional headwinds for the company's export business, forcing some factories to briefly halt production and redirect shipments to alternative markets. Despite these challenges, JBS's Australia and Seara segments continued to perform well, supported by strong export demand, value-added product growth, and favorable operating conditions. CEO Gilberto Tomazoni has stressed the company's operational flexibility, emphasizing that JBS's multi-geography platform was built to absorb trade and sanitary disruptions. The stock's decline through May, June, and early July reflected these cumulative pressures, setting the stage for the rapid recovery triggered by the Mexican cattle import announcement.
For investors seeking data-driven market insights, Tickeron's Trending AI Robots page offers a curated view of hundreds of AI-powered trading bots actively trading thousands of tickers across equities, ETFs, and cryptocurrencies. The platform filters and highlights only the top-performing and most relevant bots, allowing users to quickly identify strategies that align with their trading objectives. Each bot is designed with a distinct methodology — ranging from short-term breakout models to longer-term trend-following and pattern-recognition systems — and is accompanied by transparent performance metrics, including win rates, trade counts, and historical returns. Whether traders are focused on momentum, mean reversion, or sector rotation, the Trending AI Robots section serves as a practical starting point for exploring algorithmic trading tools backed by real-time analytics.
The most immediate catalyst for JBS is its Q2 2026 earnings report, scheduled for August 10. Analysts expect EPS of approximately $0.32 to $0.38 on revenue near $22.8 billion to $23 billion, representing a decline from the prior-year quarter's $0.52-$0.53 per share. Key areas to monitor include the magnitude of losses in the U.S. beef segment, margin trends at Pilgrim's Pride following the chicken glut, and any updates to full-year guidance. Management's commentary on the Mexican cattle import timeline and the pace of supply normalization will be closely scrutinized.
Beyond earnings, the trajectory of live cattle futures, global protein supply-demand balances, and U.S. trade policy toward Brazilian agricultural imports remain critical macro variables. The Federal Reserve's interest rate path also matters, as JBS carries a debt-to-equity ratio above 2.4x — leverage that makes the company sensitive to financing costs. On the positive side, JBS provides an approximately 8.4% dividend yield, and its forward P/E of roughly 8-9x sits well below the broader consumer staples sector, suggesting potential value if operational headwinds ease. Institutional inflows during the second quarter indicate continued interest from large asset managers, though the elevated short float of approximately 14% signals ongoing skepticism in parts of the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
JBS saw its Momentum Indicator move above the 0 level on August 18, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where JBS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
JBS moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for JBS crossed bullishly above the 50-day moving average on July 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JBS advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 234 cases where JBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for JBS moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for JBS turned negative on August 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
JBS broke above its upper Bollinger Band on July 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.420) is normal, around the industry mean (8.291). P/E Ratio (12.664) is within average values for comparable stocks, (36.469). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.951). Dividend Yield (0.074) settles around the average of (0.054) among similar stocks. P/S Ratio (0.157) is also within normal values, averaging (5.765).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows